vimarsana.com

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA

Card image cap

This study examines whether the addition of bisoprolol to treatment of people with chronic obstructive pulmonary disease (COPD) at high risk of

Related Keywords

United States , Edinburgh , City Of , United Kingdom , Australia , Singapore , San Diego , California , Lothian , Midlothian , Manchester , Scotland , American , British , Participantsthe Bisoprolol , Sanofi Genzyme , Graham Devereux , American Thoracic Society European Respiratory , Manchester Biomedical Research Centre , Health Services Research Unit , Novartis , Scotlanda Research Ethics Committee , Pragmatic Research Institute Singapore , Astrazeneca , Cipla , Care Research , Lothian Respiratory Managed Clinical Network , Hull Airway Reflux Questionnaire , Centre For Healthcare Randomized Trials , University Of Aberdeen , Pfizer , University Of Edinburgh , Regulatory Agency , Patient Care Ltd Australia , Global Initiative For Chronic Obstructive Lung Disease , Pbritish Thoracic Society , Boehringer Ingelheim , Liverpool School Of Tropical Medicine , Health Technology Assessment , United Kingdom National Health Service , Celgene Corporation , United Kingdom Department Of Health , Bristol Myers Squibb , R Foundation For Statistical Computing , Pragmatic Research Institute , Scientist Office Of The Scottish Government Health , Development Ltd , Teva Pharmaceuticals , National Institute For Health , Regeneron Pharmaceuticals , Acute Exacerbations , Chronic Obstructive Pulmonary Disease , Research Ethics Committee , Consolidated Standards , Reporting Trials , Healthcare Randomized Trials , Baseline Dyspnea Index , Transition Dyspnea Index , American Thoracic , European Respiratory Society , Size Calculation , Statistical Computing , Airway Reflux Questionnaire , Prespecified Analyses , Global Initiative , Chronic Obstructive Lung Disease , Liverpool School , Tropical Medicine , Drs Devereux , Interest Disclosures , National Institute , Scottish Government , Care Action Plan , Mechanism Evaluation Board , Optimum Patient Care Ltd , United Kingdom Efficacy , Mechanism Evaluation , British Thoracic , Trevi Therapeutics , Biomedical Research , Chief Scientist Office , Scottish Government Health , Social Care , United Kingdom Department ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.